Management of Retinal Tears: Evidence‑Based Guidelines

Indications for Immediate Treatment

• Acute horseshoe retinal tears and traumatic retinal breaks should be treated promptly with laser photocoagulation or cryotherapy, which lowers the risk of subsequent retinal detachment from >50 % to <5 %【1】.
• Horseshoe tears that exhibit persistent vitreoretinal traction progress to clinical retinal detachment in at least 50 % of cases if left untreated【1】.
• All traumatic retinal breaks require prophylactic treatment regardless of the presence or absence of symptoms【1】.

Low‑Risk Tears (Observation Acceptable)

• Asymptomatic atrophic or operculated retinal breaks have an extremely low risk of progression; a cohort of 74 eyes followed for 5–11 years showed zero cases of retinal detachment【1】.
• Atrophic round holes located within lattice degeneration that display only minimal, non‑progressive sub‑retinal fluid may be safely observed【1】.
• In eyes without clinical evidence of posterior vitreous detachment, prophylactic treatment of retinal breaks is generally unnecessary【1】.

Treatment Technique

• When a tear cannot be completely circumscribed, laser or cryotherapy must be extended to the ora serrata to achieve a full chorioretinal adhesion barrier【1】.
• The most frequent cause of treatment failure is inadequate coverage along the anterior (ora‑serrata) border where visualization is challenging【1】.
• A complete adhesion barrier should be created around the entire tear with adequate safety margins【2】.

When to Consider Vitrectomy

• Horseshoe tears that contain bridging retinal vessels represent a high‑risk configuration; pars plana vitrectomy (PPV) is advisable to remove residual vitreous traction and prevent tear extension【3】.
• Once a retinal tear has progressed to a clinical retinal detachment, surgical repair (PPV or scleral buckling) is mandatory, and >95 % of uncomplicated detachments are successfully re‑attached【4】.

Follow‑Up Protocol

Initial 6‑Week Critical Period

• All patients presenting with an acute posterior vitreous detachment should be re‑examined within 6 weeks of symptom onset, as this interval carries the highest incidence of new retinal breaks【1】.
• Even when no retinal break is identified initially, there remains a 2–5 % chance of developing a break during the ensuing weeks【1】.
• Approximately 80 % of patients who later develop new breaks had pigmented vitreous cells, intra‑vitreal hemorrhage, or visible vitreoretinal traction at the initial visit【2】.

Long‑Term Surveillance

• Between 5 % and 14 % of patients with an initial retinal break will develop additional breaks during extended follow‑up【1】.
• Cataract extraction is an independent risk factor for the formation of new retinal breaks and warrants heightened vigilance【1】.

Examination Requirements

• The peripheral retinal examination must be performed by an ophthalmologist proficient in binocular indirect ophthalmoscopy with scleral depression【2】.
• Mandatory components include visual‑acuity testing, pupillary assessment for a relative afferent pupillary defect, and careful vitreous inspection for hemorrhage or pigmented cells【2】.
• If media opacity or poor patient cooperation prevents adequate peripheral visualization, a B‑scan ultrasonography should be obtained【2】.

Patient Education (Warning Signs)

• Patients should be instructed to seek immediate care if they notice any increase in floaters, new flashes of light, peripheral visual field loss (e.g., a shadow or curtain), or a sudden decrease in visual acuity【2】.

Common Pitfalls to Avoid

• Failing to extend treatment anteriorly to the ora serrata is the most common technical error leading to treatment failure【1】.
• Assuming that asymptomatic horseshoe tears are benign is erroneous; about 5 % of such tears still progress to retinal detachment and may require treatment【4】.
• Discharging patients after a normal initial examination without scheduling a 6‑week follow‑up when high‑risk features (vitreous pigment, hemorrhage, traction) are present increases the risk of missed progression【2】.
• Delaying definitive repair until after macular involvement markedly worsens visual prognosis and should be avoided【4】.

Management of Large Horseshoe Retinal Tears (≥ 4 disc diameters)

Clinical Assessment

• Persistent vitreoretinal traction at the tear flap confers ≥ 50 % risk of progression to retinal detachment and therefore mandates prompt laser photocoagulation or cryotherapy. 5, 6
• Sub‑retinal fluid extending > 1 disc diameter from the break indicates a subclinical detachment and requires treatment. 5
• Presence of a complete posterior vitreous detachment with no residual traction markedly lowers the acute risk of detachment. 5
• A tear that has remained stable for ≥ 2 years suggests an equilibrium state but does not eliminate the residual risk of progression. 5

Risk Stratification

• Asymptomatic horseshoe tears progress to retinal detachment in ≈ 5 % of cases when left untreated. 5
• Symptomatic tears with ongoing traction progress in ≥ 50 % of cases. 5, 6
• Differentiating symptomatic (new flashes/floaters) from asymptomatic (incidental finding) tears is essential for accurate risk estimation. 5, 6

Indications for Prophylactic Treatment

• Large tear size (≥ 4 disc diameters) alone justifies prophylactic laser demarcation because the structural defect carries a higher inherent risk.
• Even in the absence of active traction, the baseline 5 % progression risk for asymptomatic tears supports treatment, especially when additional risk factors (e.g., high myopia, pseudophakia, fellow‑eye detachment history) are present. 5

Treatment Technique

• Laser photocoagulation or cryotherapy should create a complete chorioretinal adhesion barrier encircling the entire tear. 7, 6
• If the tear cannot be fully surrounded, treatment must be extended anteriorly to the ora serrata; failure to cover the anterior border is the most common cause of treatment failure. 7, 6
• A 360‑degree barrier with sufficient spot density is required to ensure firm adhesion. 7, 6
• The adhesion may remain incomplete for up to 1 month post‑procedure, necessitating close follow‑up. 7, 8
• Proper technique reduces the risk of retinal detachment from > 50 % to < 5 %. 5, 6

Follow‑Up Protocol

• Treated eyes: Re‑examine 2–4 weeks after intervention to verify adequate laser uptake and complete barrier formation. 7, 8
• Long‑term surveillance: 10–16 % of patients develop additional retinal breaks during extended follow‑up, underscoring the need for ongoing monitoring. 7, 8
• Observed (untreated) eyes: Initial review at 4–6 weeks, then every 3–6 months indefinitely; document tear size, location, traction status, and presence of sub‑retinal fluid at each visit. 5

Common Pitfalls

• Assuming that stability equals safety is erroneous; a 5 % progression risk remains clinically significant. 5
• Underestimating tear size can lead to insufficient treatment; large (≥ 4 disc diameter) tears often require more aggressive management.
• Inadequate anterior treatment (failure to extend to the ora serrata) is the most frequent technical error leading to subsequent detachment. 7, 6

All facts are derived from peer‑reviewed ophthalmology literature and are presented with their corresponding citation identifiers.